Cesar Martin Leyva Molina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cesar Martin Leyva Molina has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
A. C. Rodrigues
Mammalian Systematics Laboratory - Sorocaba, Postgraduate Program in Fauna Conservation (PPGCFAU), Federal University of São Carlos, São Paulo, Brazil
1 shared publication- Amanda Lopes da Silva
Universidade de São Paulo, Brasil
1 shared publication - Andrea Carhuallanqui
Public Health and Environmental Health Laboratory, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru
1 shared publication - Bruno Luiz Miranda Guedes
Universidade de São Paulo, Paulo
1 shared publication - Camila Malta Romano
Faculdade de Medicina, Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo, Brazil
1 shared publication Daphne Doris Ramos Delgado
Laboratorio de Salud Pública y Salud Ambiental, Facultad de Medicina Veterinaria, Universidad Nacional Mayor de San Marcos, Lima
1 shared publication
Latest Publications
- 17 February 2025
- Published by Springer Nature in Journal of Molecular Evolution
- Vol. 93 (2) , 257-266
Detection of an Alphacoronavirus in a Brazilian Bat (Molossus sp.)
Due to the COVID-19 pandemic and the uncertainty about aspects of its origin, in recent years there has been an increased interest in investigating coronaviruses in wild animals. Bats are hosts of the greatest diversity of coronaviruses to date, including the ancestors of viruses that have caused outbreaks in humans. Although in Brazil, information on coronaviruses in bats has expanded, still they remain unrepresentative. To help shed some light on this matter, we collected 175 samples from bats of different species from two Brazilian states. Here, we report the previously unknown presence of an alphacoronavirus in a bat (Molossus sp.) from Ceará. The phylogenetic analysis showed close relationships with alphacoronaviruses from Brazil and Argentina, but it was not possible to determine the subgenus or species of this virus using RNA-dependent RNA-polymerase (RdRp) domain of the nsp12 protein-coding sequence as it was distant from the specimens considered by the International Committee on Taxonomy of Viruses (ICTV). Finally, by performing High-Throughput Sequencing, we were able to find contigs mostly belonging to domains of the replicase of bat coronaviruses related to American bats of the Molossidae and Vespertilionidae families.
- 17 February 2025
- Published by Springer Nature in Journal of Molecular Evolution
- Vol. 93 (2) , 257-266
Detection of an Alphacoronavirus in a Brazilian Bat (Molossus sp.)
Due to the COVID-19 pandemic and the uncertainty about aspects of its origin, in recent years there has been an increased interest in investigating coronaviruses in wild animals. Bats are hosts of the greatest diversity of coronaviruses to date, including the ancestors of viruses that have caused outbreaks in humans. Although in Brazil, information on coronaviruses in bats has expanded, still they remain unrepresentative. To help shed some light on this matter, we collected 175 samples from bats of different species from two Brazilian states. Here, we report the previously unknown presence of an alphacoronavirus in a bat (Molossus sp.) from Ceará. The phylogenetic analysis showed close relationships with alphacoronaviruses from Brazil and Argentina, but it was not possible to determine the subgenus or species of this virus using RNA-dependent RNA-polymerase (RdRp) domain of the nsp12 protein-coding sequence as it was distant from the specimens considered by the International Committee on Taxonomy of Viruses (ICTV). Finally, by performing High-Throughput Sequencing, we were able to find contigs mostly belonging to domains of the replicase of bat coronaviruses related to American bats of the Molossidae and Vespertilionidae families.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e0110
Two Decades of Human Rabies in Brazil: Epidemiological Trends, Emerging Risks and Treatment Challenges
Background: Rabies poses a serious public health challenge in Brazil, and its epidemiology has undergone significant changes over the past two decades. Although canine transmission of rabies has been controlled through national vaccination programs, new risks have emerged, particularly from wildlife reservoirs. Methods: We performed a retrospective analysis of human rabies cases reported in Brazil between 2001 and 2025 using epidemiological surveillance data, scientific literature, and public health reports. We focused on trends in transmission sources, changes in affected populations, and challenges in prevention and treatment, particularly regarding the availability of post-exposure prophylaxis (PEP). Results: A total of 188 human rabies cases were reported in Brazil between 2001 and 2025 (average: 7.52 cases per year). Most of the cases occurred in the northern and northeastern regions of the country. Bats were the most common source of transmission, followed by dogs and non-human primates. Although rabies is preventable, most of the cases reported within the study period resulted in death. PEP was administered in most cases; however, the treatment may have been delayed, incomplete, or initiated after the onset of symptoms, which limited its effectiveness. Only two patients survived, and both of them received intensive care and were treated using modified therapeutic protocols. Conclusion: The transition from canine- to bat-mediated rabies highlights the need for enhanced surveillance and targeted prevention strategies. Despite advances in canine rabies control, ensuring PEP accessibility and strengthening public health interventions in high-risk areas remain critical for reducing the incidence of human rabies in Brazil.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 58, e0110
Open AccessTwo Decades of Human Rabies in Brazil: Epidemiological Trends, Emerging Risks and Treatment Challenges
Background: Rabies poses a serious public health challenge in Brazil, and its epidemiology has undergone significant changes over the past two decades. Although canine transmission of rabies has been controlled through national vaccination programs, new risks have emerged, particularly from wildlife reservoirs. Methods: We performed a retrospective analysis of human rabies cases reported in Brazil between 2001 and 2025 using epidemiological surveillance data, scientific literature, and public health reports. We focused on trends in transmission sources, changes in affected populations, and challenges in prevention and treatment, particularly regarding the availability of post-exposure prophylaxis (PEP). Results: A total of 188 human rabies cases were reported in Brazil between 2001 and 2025 (average: 7.52 cases per year). Most of the cases occurred in the northern and northeastern regions of the country. Bats were the most common source of transmission, followed by dogs and non-human primates. Although rabies is preventable, most of the cases reported within the study period resulted in death. PEP was administered in most cases; however, the treatment may have been delayed, incomplete, or initiated after the onset of symptoms, which limited its effectiveness. Only two patients survived, and both of them received intensive care and were treated using modified therapeutic protocols. Conclusion: The transition from canine- to bat-mediated rabies highlights the need for enhanced surveillance and targeted prevention strategies. Despite advances in canine rabies control, ensuring PEP accessibility and strengthening public health interventions in high-risk areas remain critical for reducing the incidence of human rabies in Brazil.
- Open Access
- 11 August 2020
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Revista de Investigaciones Veterinarias del Perú
- Vol. 31 (3) , e18726
Detección de residuos de enrofloxacina por microbiología (prueba de inhibición del crecimiento) y ELISA en cuyes (Cavia porcellus) en la provincia de Jauja, Perú
El presente estudio tuvo como objetivo detectar la posible presencia de enrofloxacina en cuyes destinados al consumo humano en la provincia de Jauja, Región Junín, Perú. Para la detección de enrofloxacina se tomaron muestras de hígado, riñón y diafragma de 200 cuyes de dos mataderos de la provincia de Jauja. La detección de residuos de antibióticos se realizó utilizando la prueba microbiológica de Inhibición del Crecimiento en las tres muestras, obteniéndose resultados negativos en todas ellas. Se tomaron al azar 30 de estas muestras y se analizaron mediante la prueba de ELISA con un kit comercial específico para enrofloxacina en muestras de hígado, obteniéndose 26.7% (8/30) de muestras positivas, con concentraciones entre 1.11 y 35.1 μg/kg. Los resultados demuestran la presencia de residuos de enrofloxacina en concentraciones permitidas por las normativas sanitarias en cuyes destinados al consumo humano.
- 11 August 2020
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Revista de Investigaciones Veterinarias del Perú
- Vol. 31 (3) , e18726
Open AccessDetección de residuos de enrofloxacina por microbiología (prueba de inhibición del crecimiento) y ELISA en cuyes (Cavia porcellus) en la provincia de Jauja, Perú
El presente estudio tuvo como objetivo detectar la posible presencia de enrofloxacina en cuyes destinados al consumo humano en la provincia de Jauja, Región Junín, Perú. Para la detección de enrofloxacina se tomaron muestras de hígado, riñón y diafragma de 200 cuyes de dos mataderos de la provincia de Jauja. La detección de residuos de antibióticos se realizó utilizando la prueba microbiológica de Inhibición del Crecimiento en las tres muestras, obteniéndose resultados negativos en todas ellas. Se tomaron al azar 30 de estas muestras y se analizaron mediante la prueba de ELISA con un kit comercial específico para enrofloxacina en muestras de hígado, obteniéndose 26.7% (8/30) de muestras positivas, con concentraciones entre 1.11 y 35.1 μg/kg. Los resultados demuestran la presencia de residuos de enrofloxacina en concentraciones permitidas por las normativas sanitarias en cuyes destinados al consumo humano.